Event-Driven Stocks

Penumbra Inc

PENNYSE

Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 6 gooddetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$1.40B$1.19B$1.06B$847.1M$747.6M$137.3M
Operating income$189.2M$9.3M$73.6M$6.1M−$7.5M−$38.9M
Net income$177.7M$14.0M$91.0M−$2.0M$5.3M$1.4M
Total assets$1.83B$1.53B$1.56B$1.37B$1.24B$823.0M
Total liabilities$398.9M$382.3M$377.4M$372.0M$290.3M$185.2M
Equity$1.43B$1.15B$1.18B$998.9M$953.9M$641.5M
EPS (diluted)$4.52$0.36$2.32$-0.05$0.14$0.04
Shares out.38.5M38.7M38.2M37.7M36.4M35.1M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
13.5%
Net margin
12.7%
Return on equity
12.4%
Return on assets
9.7%
Return on capital (ROCE)
11.5%
Liabilities / assets
21.8%
Debt / equity
0.28×
Book value / share
$37.07
Revenue growth (YoY)
17.5%
Net income growth (YoY)
1168.1%

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
8.59safe
Accruals / assets
−3.3%clean
Beneish M-Score
-2.45normal
Piotroski F-Score
8/9strong

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
87
/ 100
Profitability 100Growth 100Catalyst 33Earnings quality 100Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 6 good
  • Operating margin is positive
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Positive operating cash flow
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20261.9M4.7+1.0%
Apr 30, 20261.9M3.3-5.5%
Apr 15, 20262.0M4.2-17.7%
Mar 31, 20262.4M3.7+18.3%
Mar 13, 20262.1M3.1+10.4%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)